QTREX Quantum Ltd.

QTREX Quantum Ltd. (NASDAQ: QTEX) is an Israel-based technology company headquartered in Ra’anana, focused on advanced manufacturing, high-performance electronics, and quantum connectivity infrastructure. Originally incorporated in 2018 as Inspira Technologies Oxy B.H.N. Ltd., the company built its foundation on proprietary life support technologies before undergoing a strategic transformation. Shareholders approved a corporate name change in May 2026, with trading under the new ticker “QTEX” beginning May 20 of that year, reflecting a broadened focus on its Additively Manufactured Electronics (AME) platform.

The company continues to maintain its medical technology portfolio alongside its newer hardware initiatives. Its INSPIRA ART100 is a life support system designed for cardiopulmonary bypass procedures lasting up to six hours, complemented by the HYLA blood sensor, which enables real-time sampling and analysis of key blood parameters without requiring manual draws. Management is actively working to monetize parts of this medical business while directing core resources toward quantum engineering applications.

On July 6, 2026, QTREX announced a significant commercial milestone: a prominent U.S. government research laboratory focused on national security is now actively operating the company’s AME system. The platform builds monolithic interconnect structures that integrate conductors, RF dielectrics, shielding, thermal management, and routing into a single engineered system — addressing critical hardware bottlenecks in quantum computing infrastructure. QTREX views this federal deployment as a springboard for deeper technical engagement and broader expansion across defense and advanced hardware markets.